DE GASPARI, MONICA
 Distribuzione geografica
Continente #
NA - Nord America 2.852
AS - Asia 2.474
EU - Europa 2.003
AF - Africa 702
SA - Sud America 632
OC - Oceania 67
Continente sconosciuto - Info sul continente non disponibili 26
Totale 8.756
Nazione #
US - Stati Uniti d'America 2.476
SG - Singapore 941
IT - Italia 775
CN - Cina 369
BR - Brasile 365
HK - Hong Kong 280
VN - Vietnam 162
FI - Finlandia 135
DE - Germania 128
NL - Olanda 86
PL - Polonia 81
GB - Regno Unito 75
AR - Argentina 60
BJ - Benin 52
MX - Messico 52
FR - Francia 51
RU - Federazione Russa 49
SE - Svezia 48
EC - Ecuador 43
IN - India 43
KR - Corea 39
IQ - Iraq 37
AT - Austria 36
JP - Giappone 33
ZA - Sudafrica 33
VE - Venezuela 32
ID - Indonesia 31
CA - Canada 30
ES - Italia 30
UZ - Uzbekistan 28
TH - Thailandia 27
TR - Turchia 27
CI - Costa d'Avorio 26
IR - Iran 26
MD - Moldavia 26
NI - Nicaragua 26
UY - Uruguay 26
CH - Svizzera 25
CZ - Repubblica Ceca 25
UA - Ucraina 25
GR - Grecia 24
KE - Kenya 24
CL - Cile 23
CV - Capo Verde 23
ET - Etiopia 23
GE - Georgia 23
NO - Norvegia 23
PK - Pakistan 23
BE - Belgio 22
BY - Bielorussia 22
GF - Guiana Francese 22
HT - Haiti 22
IE - Irlanda 22
LV - Lettonia 22
AL - Albania 21
BD - Bangladesh 21
BW - Botswana 21
DK - Danimarca 21
EG - Egitto 21
GH - Ghana 21
HU - Ungheria 21
JM - Giamaica 21
MA - Marocco 21
MY - Malesia 21
NP - Nepal 21
PA - Panama 21
TT - Trinidad e Tobago 21
CR - Costa Rica 20
GT - Guatemala 20
IL - Israele 20
KG - Kirghizistan 20
TZ - Tanzania 20
AO - Angola 19
AU - Australia 19
CO - Colombia 19
HN - Honduras 19
KZ - Kazakistan 19
ME - Montenegro 19
TJ - Tagikistan 19
GN - Guinea 18
LB - Libano 18
PY - Paraguay 18
AE - Emirati Arabi Uniti 17
AZ - Azerbaigian 17
BF - Burkina Faso 17
CM - Camerun 17
DO - Repubblica Dominicana 17
GA - Gabon 17
KH - Cambogia 17
MR - Mauritania 17
SK - Slovacchia (Repubblica Slovacca) 17
SO - Somalia 17
YE - Yemen 17
CW - ???statistics.table.value.countryCode.CW??? 16
GM - Gambi 16
IS - Islanda 16
JO - Giordania 16
MK - Macedonia 16
PS - Palestinian Territory 16
TN - Tunisia 16
Totale 8.036
Città #
Singapore 481
Ashburn 410
Fairfield 264
Hong Kong 264
Beijing 156
Chandler 110
Milan 96
San Jose 95
Cambridge 86
Woodbridge 86
Los Angeles 82
Helsinki 79
Houston 74
Ho Chi Minh City 67
Boardman 65
Munich 61
Santa Clara 60
Seattle 59
Padova 56
Villafranca Padovana 53
Chicago 51
New York 50
Bytom 49
Cotonou 49
San Diego 49
Rome 43
Wilmington 42
São Paulo 41
Hefei 40
Hanoi 31
Turku 30
Ann Arbor 28
Buffalo 27
Tashkent 27
Turin 27
Vienna 27
Abidjan 26
Managua 25
Medford 25
Princeton 24
Nairobi 22
Nuremberg 22
Orem 22
Seoul 22
Bologna 21
Montevideo 21
Padua 21
Panama City 21
Warsaw 21
London 20
Dar es Salaam 19
Mexico City 19
Praia 19
Riga 19
Accra 18
Bishkek 18
Conakry 18
Des Moines 18
Johannesburg 18
Lappeenranta 18
Minsk 18
Baku 17
Cayenne 17
Chisinau 17
Podgorica 17
San José 17
Brooklyn 16
Denver 16
Dublin 16
Dushanbe 16
Guayaquil 16
Libreville 16
Phnom Penh 16
Amman 15
Dakar 15
Gaborone 15
Luanda 15
Niamey 15
Nouakchott 15
Reykjavik 15
Roxbury 15
Tirana 15
Trieste 15
Atlanta 14
Bridgetown 14
Kampala 14
Manchester 14
Ouagadougou 14
Redondo Beach 14
Stockholm 14
Tbilisi 14
Ulan Bator 14
Chennai 13
Havana 13
Kingstown 13
Lusaka 13
Naples 13
Port-au-Prince 13
Quito 13
Tampa 13
Totale 4.407
Nome #
'Hot phase' clinical presentation in arrhythmogenic cardiomyopathy 480
Relative apical sparing in cardiac amyloidosis is not always explained by an amyloid gradient 248
Endomyocardial fibrosis and myocardial infarction leading to diastolic and systolic dysfunction requiring transplantation 239
Predictors of relapse, death or heart transplantation in myocarditis before the introduction of immunosuppression: negative prognostic impact of female gender, fulminant onset, lower ejection fraction and serum autoantibodies 212
Long-term efficacy and safety of tailored immunosuppressive therapy in immune-mediated biopsy-proven myocarditis: a propensity weighted study. 168
Filamin C variant-associated Cardiomyopathy: A Pooled Analysis of Individual Patient Data to Evaluate the Clinical Profile and Risk of Sudden Cardiac Death 168
A Comprehensive Analysis of Non-Desmosomal Rare Genetic Variants in Arrhythmogenic Cardiomyopathy: Integrating in Padua Cohort Literature-Derived Data 167
Causes of sudden cardiac arrest and death and the diagnostic yield of sport preparticipation screening in children 165
A Machine-Learning Model for the Prognostic Role of C-Reactive Protein in Myocarditis 165
Update on cardiomyopathies and sudden cardiac death 163
A standardized postmortem protocol to assess the real burden of sudden infant death syndrome 160
Myocardial Tissue Characterization in Arrhythmogenic Cardiomyopathy: Comparison Between Endomyocardial Biopsy and Cardiac Magnetic Resonance 159
Multi-Design Differential Expression Profiling of COVID-19 Lung Autopsy Specimens Reveals Significantly Deregulated Inflammatory Pathways and SFTPC Impaired Transcription 158
Clinical profile and long-term follow-up of a cohort of patients with desmoplakin cardiomyopathy 150
CMR Predictors of Favorable Outcome in Myocarditis: A Single-Center Experience 148
The 'Padua classification' of cardiomyopathies into three groups: hypertrophic/restrictive, dilated/hypokinetic, and scarring/arrhythmogenic 140
Anatomy of the cavotricuspid isthmus for radiofrequency ablation in typical atrial flutter 139
A rare cause of effusive–constrictive pericarditis 138
End-stage heart failure secondary to low-dose hydroxychloroquine treatment 135
Causes of sudden death 134
The missing pieces in the puzzle of arrhythmic mitral valve prolapse: papillary muscles, mitral anulus disjunction and myocardial scarring 132
Detection of SARS-CoV-2 viral proteins and genomic sequences in human brainstem nuclei 131
Small Vessel Disease: Another Component of the Hypertrophic Cardiomyopathy Phenotype Not Necessarily Associated with Fibrosis 130
Light-chain cardiac amyloidosis for the non-expert: pearls and pitfalls 130
Sudden Death and Coronary Artery Anomalies 126
Cardiac rupture in acute myocardial infarction: a cardiac magnetic resonance study 125
Right ventricular to pulmonary artery uncoupling is an early predictor of poor outcome in wild-type transthyretin amyloid cardiomyopathy 121
Clinical management of a pregnant woman with Filamin C cardiomyopathy 121
Is Congenital Muscular Mitral-Aortic Discontinuity Another Feature of Obstructive Hypertrophic Cardiomyopathy? A Pathology Validation Study 120
In Vivo Approaches to Understand Arrhythmogenic Cardiomyopathy: Perspectives on Animal Models 120
Transcatheter ablation of the atrioventricular junction in refractory atrial fibrillation: A clinicopathological study 119
The Role of the Immune System in Pathobiology and Therapy of Myocarditis: A Review 117
A cardiac intimal sarcoma mimicking infective endocarditis 117
An intracardiac mass arising from the coronary sinus 117
Chest pain in cardiac amyloidosis: occurrence, causes and prognostic significance 115
Sudden coronary death in the young: Evidence of contractile phenotype of smooth muscle cells in the culprit atherosclerotic plaque 115
Additional diagnostic value of cardiac magnetic resonance feature tracking in patients with biopsy-proven arrhythmogenic cardiomyopathy 112
Pathological features of COVID-19-associated myocardial injury: a multicentre cardiovascular pathology study 108
Myocarditis and inflammatory bowel diseases: A single-center experience and a systematic literature review 108
Cardiac magnetic resonance in the assessment of the anomalous right coronary artery originating from the left sinus of Valsalva 104
Low QRS Voltages in Cardiac Amyloidosis: Clinical Correlates and Prognostic Value 103
Prevalence, Characteristics, and Outcomes of COVID-19-Associated Acute Myocarditis 102
Rate and Cause of Sudden Cardiac Death in the Young During the COVID-19 Pandemic and Vaccination 99
Characteristics and Clinical Value of Electroanatomical Voltage Mapping in Cardiac Amyloidosis 98
Multiple mycotic aneurysms of the aortic root after aortic valve replacement 96
Clinical profiling and outcomes of viral myocarditis manifesting with ventricular arrhythmias 95
Clinical Applications of FDG-PET Scan in Arrhythmic Myocarditis 95
New-Onset Exertional Dyspnea in a Young Patient With Previous Blunt Chest Trauma 94
Circulating c-Met-Expressing Memory T Cells Define Cardiac Autoimmunity 94
Endomyocardial biopsy: The forgotten piece in the arrhythmogenic cardiomyopathy puzzle 94
Exercise Stress Test Late after Arrhythmic versus Nonarrhythmic Presentation of Myocarditis 92
Immune checkpoint inhibitor myocarditis: a call for standardized histopathologic criteria 91
Cardiovascular pathology in vasculitis 89
Consensus statement on the processing, interpretation and reporting of temporal artery biopsy for arteritis 88
Cardiac magnetic resonance abnormalities in patients with acute myocarditis proven by septal endomyocardial biopsy 82
Sudden cardiac death caused by Kawasaki coronary artery vasculitis in a child with Hodgkin's lymphoma. Case report and literature review 78
Hydrocarbon Exposure in Myocarditis: Rare Toxic Cause or Trigger? Insights from a Biopsy-Proven Fulminant Viral Case and a Systematic Literature Review 78
Storytelling of Hypertrophic Cardiomyopathy Discovery 76
Unexpected Aortitis Mimicking an Ascending Aorta Intramural Hematoma in Ankylosing Spondylitis 73
The spectrum of covid-19-associated myocarditis: A patient-tailored multidisciplinary approach 73
Feasibility and Safety of a Three-Dimensional Sheath for Right Ventricular Septal Endomyocardial Biopsy 71
The workup of ventricular arrhythmias: the ongoing search for a non-invasive tool to diagnose myocardial inflammation 70
Multimodal Detection and Targeting of Biopsy-Proven Myocardial Inflammation in Genetic Cardiomyopathies: A Pilot Report 70
Multifactorial Predisposition in Biopsy-Proven Autoimmune and Viral Myocarditis 68
The Morphologic Spectrum of the Tricuspid Valve: Anatomical Implications for Transcatheter Edge-to-Edge Repair 68
Genetically determined cardiomyopathies at autopsy: the pivotal role of the pathologist in establishing the diagnosis and guiding family screening 68
Clinical impact of follow‐up endomyocardial biopsy in myocarditis during or after immune‐suppressive therapy 66
Recurrent arrhythmic storms and unsuccessful catheter ablation in chronic ischemic heart disease 61
Inflammation on Endomyocardial Biopsy Predicts Risk of MACE in Undefined Left Ventricular Arrhythmogenic Cardiomyopathy 61
Advancing diagnosis in a cardiac arrest case and suspected MINOCA: the complementary roles of imaging, biopsy, and genetic testing 58
Diagnosing myocarditis in endomyocardial biopsies: survey of current practice 55
ANMCO position paper 'Hypertrophic cardiomyopathy: from diagnosis to treatment' 54
Congo red fluorescence enhances digital pathology workflow in cardiac amyloidosis 53
Adipose Tissue in and Around the Heart: Structural and Functional Insights From Cardiac Magnetic Resonance 52
Serum Anti-Heart and Antinuclear Autoantibodies Are Independent Predictors of Response to Immunosuppressive Therapy in Autoimmune Biopsy-Proven Inflammatory Cardiomyopathy 51
Ischemic and non-ischemic myocardial injuries at autopsy- an overview for forensic pathologists 48
Can DSP Mutation Carriers Safely Participate in Sport Activity?: A Word of Caution 31
New pathological insights into arrhythmogenic cardiomyopathy: implications for non-invasive diagnosis 31
Patent foramen ovale: A variant of normal or a true congenital heart disease? 24
The frequency of CD3+ lymphocytes in non-myocarditis endomyocardial biopsies 23
Lymphocytic myocarditis: A histopathologic definition and classification from the Society for Cardiovascular Pathology and Association for European Cardiovascular Pathology. II: Surgical and autopsy specimens 12
Totale 8.909
Categoria #
all - tutte 27.477
article - articoli 27.392
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.869


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021176 0 0 0 0 0 0 33 17 25 73 11 17
2021/2022531 3 57 113 13 11 19 22 102 57 10 33 91
2022/2023307 57 22 10 33 36 27 7 16 37 14 32 16
2023/2024529 20 45 48 69 41 36 61 30 40 18 53 68
2024/20252.051 23 154 123 102 134 63 178 180 170 137 286 501
2025/20265.078 489 497 1.223 1.522 700 438 209 0 0 0 0 0
Totale 8.909